These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [The scintigraphy of somatostatin receptors in the carcinoid tumor]. Banzo J, Abós MD, Prats E, Delgado M, Razola P, García S, Gomollón F, García F. Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324 [Abstract] [Full Text] [Related]
11. Iodine-123-Tyr-3-octreotide uptake in pancreatic endocrine tumors and in carcinoids in relation to hormonal inhibition by octreotide. Nocaudie-Calzada M, Huglo D, Deveaux M, Carnaille B, Proye C, Marchandise X. J Nucl Med; 1994 Jan; 35(1):57-62. PubMed ID: 8271061 [Abstract] [Full Text] [Related]
17. [Receptor scintigraphy in endocrine gastrointestinal and pancreatic tumors]. Joseph K, Stapp J, Reinecke J, Höffken H, Benning R, Neuhaus C, Trautmann ME, Schwerk WB, Arnold R. Dtsch Med Wochenschr; 1992 Jun 26; 117(26):1025-8. PubMed ID: 1352234 [No Abstract] [Full Text] [Related]
18. Improved visualization of carcinoid liver metastases by indium-111 pentetreotide scintigraphy following treatment with cold somatostatin analogue. Dörr U, Räth U, Sautter-Bihl ML, Guzman G, Bach D, Adrian HJ, Bihl H. Eur J Nucl Med; 1993 May 26; 20(5):431-3. PubMed ID: 8100192 [Abstract] [Full Text] [Related]
19. Somatostatin receptor scintigraphy of malignant somatostatinoma with indium-111-pentetreotide. Schillaci O, Annibale B, Scopinaro F, delle Fave G, Colella AC. J Nucl Med; 1997 Jun 26; 38(6):886-7. PubMed ID: 9189135 [Abstract] [Full Text] [Related]
20. Incremental diagnostic value and impact on patient management of somatostatin receptor scintigraphy with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors. Usmani S, Khan HA, Abdulla M, Ahmed N, abu Huda F, Marafi F, al Kandari F, al Mohannadi S, al Nafisi N. Med Princ Pract; 2011 Jun 26; 20(4):356-61. PubMed ID: 21576997 [Abstract] [Full Text] [Related] Page: [Next] [New Search]